Genmab
GMAB
₹1,715
Share price
0.40%
Change (1 day)
-29.00%
Change (1 year)
Categories
Revenue for Genmab (GMAB)
Revenue in 2024 (TTM): ₹261.39 Billion
According to Genmab's latest financial reports the company's current revenue (TTM 
) is ₹264.36 Billion. an increase over the revenue in the year 2023 that were of ₹198.44 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Genmab from 2009 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | ₹266.43 B | 34.26% |
| 2023 | ₹198.44 B | 16.7% |
| 2022 | ₹170.04 B | 72.56% |
| 2021 | ₹98.54 B | -13.85% |
| 2020 | ₹114.39 B | 99.75% |
| 2019 | ₹57.26 B | 72.46% |
| 2018 | ₹33.20 B | 40.39% |
| 2017 | ₹23.65 B | 31.33% |
| 2016 | ₹18.00 B | 61.56% |
| 2015 | ₹11.14 B | 18.61% |
| 2014 | ₹9.39 B | 28.23% |
| 2013 | ₹7.32 B | 58.01% |
| 2012 | ₹4.63 B | 35.23% |
| 2011 | ₹3.43 B | -25.49% |
| 2010 | ₹4.60 B | -9.15% |
| 2009 | ₹5.06 B |